DrugPatentWatch Database Preview
Meitheal Company Profile
» See Plans and Pricing
What is the competitive landscape for MEITHEAL, and what generic and branded alternatives to MEITHEAL drugs are available?
MEITHEAL has fifteen approved drugs.
Summary for Meitheal
| US Patents: | 0 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 15 |
Drugs and US Patents for Meitheal
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Meitheal | PHENYLEPHRINE HYDROCHLORIDE | phenylephrine hydrochloride | SOLUTION;INTRAVENOUS | 210334-001 | Apr 27, 2018 | AP2 | RX | No | No | Start Trial | Start Trial | ||||
| Meitheal | ATRACURIUM BESYLATE PRESERVATIVE FREE | atracurium besylate | INJECTABLE;INJECTION | 091488-001 | Feb 17, 2012 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Meitheal | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 211668-002 | Apr 25, 2019 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Meitheal | BLEOMYCIN SULFATE | bleomycin sulfate | INJECTABLE;INJECTION | 205030-002 | Apr 20, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Meitheal | CYTARABINE | cytarabine | INJECTABLE;INJECTION | 206190-001 | Nov 9, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Meitheal | TOPOTECAN HYDROCHLORIDE | topotecan hydrochloride | INJECTABLE;INJECTION | 201166-001 | Aug 8, 2012 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
